Cancer Research Institute

🌟CRI is proud to announce the 2026 class of Lloyd J. Old STARs- 5 bold scientists pushing the boundaries of immunotherapy and reimagining what’s possible in the fight against cancer. Discover how their fearless ideas are reshaping the future of treatment: bit.ly/3SDls21

What is immunotherapy, and who can receive it? What immunotherapies are approved for standard care? Get answers to your most frequently asked questions, on our website, today: bit.ly/42Rvg7X #Immunotherapy #PatientResources #CancerPatient

A new study led by @washumedicine researchers suggests that younger generations are aging biologically faster than their older counterparts. This faster biological aging was also linked to early-onset cancers. Explore: bit.ly/4xExzvH #EarlyOnsetCancers #CancerResearch

Cancer diagnosis is informed by cellular annotations of histopathology, but assays are expensive or rely on manual annotations. At #ICML2026, we present SpatialWhisperer, a trimodal model that zero-shot annotates cell types in histopathology images. 🧵👇

Cancer death rates in the US have dropped dramatically in the past 35 years- falling by 35%, according to a report from @AACR. But progress has not been seen equally across the country. Dive deeper into the disparities with @NBCNews: nbcnews.to/3T0eAeX #CancerResearch

"I literally feel like I pitched them to get into the trial. My pitch was, I’m coming to you pretty much in great health, except for this cancer that will likely kill me," says stage 4 ampullary cancer survivor, Adrienne. Read more of her inspiring story: bit.ly/4efRKbJ

I am thrilled that my postdoc Dr. Shayna Thomas-Jardin was awarded a CRI Ignite Award. This is an amazing transitional award that will fund 2 yrs of postdoc support, and 3 yrs of independent faculty support. Thank you @CancerResearch and CONGRATS Shayna! 🥳

According to a new publication from researchers including CRI Fellow Dr. Bashir & CRI LJO STAR Dr. Sonnenberg @WeillCornell, chronic stress can help tumors evade immune attack by a chain of molecular events involving gut bacteria & viruses within bacteria: bit.ly/4vzUE1d

Amid federal funding cuts, CRI is pleased to announce our largest-ever annual grantmaking of 93 awards, totaling $37 million! Explore how CRI's grantmaking spans 48 institutions across 17 states and 5 countries, and funds researchers at every career stage: bit.ly/4as6cek

👏 CRI is proud to announce the recipients of our 2026 Scientific Achievement Awards: Dr. Eric Vivier, recipient of the William B. Coley Award, and Dr. Joseph Sun, recipient of the Frederick W. Alt Award. Read more: bit.ly/4478A6D #CancerResearch #Immunotherapy

In a new study, Jeff Rathmell, PhD, and colleagues demonstrate that MMP is increased in exhausted T cells, suggesting MMP may serve as a biomarker for monitoring responses to immunotherapy treatment. @UChicagoCCB @VUMCDiscoveries @J_Immunol @JeffRathmell ow.ly/yUbl50ZigXB

“Clinical trials are an important part of modern cancer care,” says Dr. Zsiros @RoswellPark. “Clinical trials are not a last resort — they are often the pathway to the next generation of cancer treatments.” Learn more: bit.ly/43PobHU #ClinicalTrials #CancerResearch

The future of #immunotherapy is being shaped by scientists and advocates bold enough to disrupt the status quo. Join CRI in celebrating the women in STEM who remind us that breakthroughs begin with curiosity, and the courage to challenge what’s possible: bit.ly/4slFLOi

“Chronic, widespread inflammation is a driving factor in many age-related diseases, including cancer, and our research has discovered one reason why this happens,” says Dr. Rugang Zhang at @MDAndersonNews. Explore: bit.ly/4vV2wtU #CancerResearch

June is #CancerImmunotherapy Month. At Crescent, we’re developing potential next-gen therapies, with the goal of improving outcomes for people living with cancer. We join the @CancerResearch Institute in recognizing the progress of immunotherapy and its impact on patients.

How do colorectal tumors shut down immune responses? CRI Postdoctoral Fellow Dr. Jesse Boumelha from @IcahnMountSinai is mapping the suppressive myeloid programs that block effective cancer immunity — paving the way for smarter immunotherapies. Learn more: bit.ly/43ISccc

Discover how Torrey Coast Foundation GEMINI CRI CLIP Investigator Dr. Valsamo Anagnostou @JohnsHopkins is working to understand how cancers evolve during treatment, and how emerging technologies like liquid biopsies could help physicians stay a step ahead: bit.ly/4vht7Ro

When it comes to clinical trials, CRI's CEO describes, "I think that it happens too often that researchers tell you about how your data is going to help the research, but they don't do enough of connecting it back to how is it going to help you." bit.ly/4xzqPis

Breast tumors can recruit bone-derived cells that help cancer grow. In a new Nature Communications study, researchers including CRI Postdoctoral Fellow Dr. Giulia Furesi identify a potential new way to target the tumor microenvironment in #breastcancer: go.nature.com/3S7TF9D

Explore CRI's latest Cancer Immunotherapy Insights & Impact (CI3) report- the most comprehensive, publicly available account of @US_FDA immunotherapy approvals that provides a year-over-year view of how the field is evolving: bit.ly/4eg9cg0 #Immunotherapy